New Life Pharma Semaglutide Inj 2mg Vial Recall: Lack of Sterility Assurance
New Life Pharma recalls 2mg Semaglutide injections due to potential lack of sterility. This could cause infections if used. Affected units have specific lot and expiration details.
Recall notice
Lack of Assurance of Sterility
Contact the company
What happened, in plain English
New Life Pharma is recalling 2mg Semaglutide injections that may not be sterile, which could lead to infections. This recall affects patients using the medication as prescribed. Read more at govinfonow.com/recall/31468-new-life-pharma-semaglutide-inj-2mg-vial-recall-lack-of.
Source Summary by GovInfoNow · govinfonow.com/recall/31468-new-life-pharma-semaglutide-inj-2mg-vial-recall-lack-of · Updated August 17, 2026 · FDA enforcement record: FDA #D-0393-2026
Cite this page
“New Life Pharma Semaglutide Inj 2mg Vial Recall: Lack of Sterility Assurance.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31468-new-life-pharma-semaglutide-inj-2mg-vial-recall-lack-of. Based on FDA recall #D-0393-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0393-2026%22&limit=1).
Why it’s dangerous
The vials may not be sterile, meaning they could contain harmful bacteria. If injected, this could cause serious infections or other health issues. The risk is not yet confirmed but is a potential hazard.
Who’s affected
Patients prescribed Semaglutide injections by a doctor are affected. Those using the recalled vials for weight management or diabetes treatment are at risk.
How to tell if you have this one
Check for the product name 'Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial' with NDC 84223-001-06. The lot number is 240903 and expiration date is 9/30/2026.
- Brand
New Life Pharma- Category
Drug
All 4 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
OH
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0392-2026 | Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.; Lot 241113, Exp Date 11/30/2026 & Lot 250103, Exp Date 1/31/2027 | 820 vials |
| D-0393-2026 | Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06; Lot 240903, exp 9/30/2026 | 2 vials |
| D-0394-2026 | Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.; Lot 240709, exp 7/31/2026 | 23 vials |
| D-0395-2026 | Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.; Lot 240709, exp 7/31/2026 | 45 vials |
What to do — step by step
Check Product Details
Look for the NDC code 84223-001-06 and lot number 240903 on the vial label.
Where it went and when
Where it was distributed
Distributed in Ohio.
FDA distribution: “OH” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Ohio.
Recall timeline
FDA published this recall 13 days after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class II
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe to use?
The recall states there is a potential lack of sterility, but no specific safety confirmation is provided in the record.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0393-2026 (February 26, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0393-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.